Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Are orange lollies effective in preventing nausea and vomiting related to dimethyl sulfoxide? A multicenter randomized trial.

Gonella S, Berchialla P, Bruno B, Di Giulio P.

Support Care Cancer. 2014 Sep;22(9):2417-24. doi: 10.1007/s00520-014-2227-y. Epub 2014 Apr 4.

PMID:
24700260
2.

Orange interventions for symptoms associated with dimethyl sulfoxide during stem cell reinfusions: a feasibility study.

Potter P, Eisenberg S, Cain KC, Berry DL.

Cancer Nurs. 2011 Sep-Oct;34(5):361-8. doi: 10.1097/NCC.0b013e31820641a5.

PMID:
21372706
3.

The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.

Ozdemir E, Akgedik K, Akdogan S, Kansu E.

Biol Blood Marrow Transplant. 2008 Dec;14(12):1425-8. doi: 10.1016/j.bbmt.2008.09.010.

4.

Delayed chemotherapy-induced nausea and vomiting in autologous hematopoietic cell transplant patients: an exploratory analysis.

Gonella S, Giulio PD.

Tumori. 2015 Nov 14;101(6):e154-9. doi: 10.5301/tj.5000296.

PMID:
26045114
5.

Prevention of dimethylsulfoxide-related nausea and vomiting by prophylactic administration of ondansetron for patients receiving autologous cryopreserved peripheral blood stem cells.

Eisenberg S, Wickline M, Linenberger M, Gooley T, Holmberg L.

Oncol Nurs Forum. 2013 May 1;40(3):285-92. doi: 10.1188/13.ONF.285-292.

PMID:
23615140
6.
7.

Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

Barton DL, Thanarajasingam G, Sloan JA, Diekmann B, Fuloria J, Kottschade LA, Lyss AP, Jaslowski AJ, Mazurczak MA, Blair SC, Terstriep S, Loprinzi CL.

Cancer. 2014 Nov 15;120(22):3575-83. doi: 10.1002/cncr.28892. Epub 2014 Jul 9.

9.
10.
11.

Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy.

Treish I, Shord S, Valgus J, Harvey D, Nagy J, Stegal J, Lindley C.

Support Care Cancer. 2003 Aug;11(8):516-21. Epub 2003 Jun 27.

PMID:
12836088
12.
13.

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.

Hesketh PJ, Grunberg SM, Gralla RJ, Warr DG, Roila F, de Wit R, Chawla SP, Carides AD, Ianus J, Elmer ME, Evans JK, Beck K, Reines S, Horgan KJ; Aprepitant Protocol 052 Study Group.

J Clin Oncol. 2003 Nov 15;21(22):4112-9. Epub 2003 Oct 14.

PMID:
14559886
14.

Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.

Hilarius DL, Kloeg PH, van der Wall E, van den Heuvel JJ, Gundy CM, Aaronson NK.

Support Care Cancer. 2012 Jan;20(1):107-17. doi: 10.1007/s00520-010-1073-9. Epub 2011 Jan 22.

15.
16.

Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy.

Grunberg SM, Dugan M, Muss H, Wood M, Burdette-Radoux S, Weisberg T, Siebel M.

Support Care Cancer. 2009 May;17(5):589-94. doi: 10.1007/s00520-008-0535-9. Epub 2008 Nov 27.

PMID:
19037667
17.

[The effect of thalidomide in preventing delayed nausea and vomiting induced by GP regimen of chemotherapy for non-small cell lung cancer].

Yu YL, Zhu ZT, Li JP, Ha MW, Liu XM, Wu Q, Xing YD.

Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):937-40. Chinese.

PMID:
20193338
18.

Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster.

Pirri C, Bayliss E, Trotter J, Olver IN, Katris P, Drummond P, Bennett R.

Support Care Cancer. 2013 Mar;21(3):735-48. doi: 10.1007/s00520-012-1574-9. Epub 2012 Sep 14.

PMID:
22976921
19.

Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.

Walsh T, Morris AK, Holle LM, Callander N, Bradshaw P, Valley AW, Clark G, Freytes CO.

Bone Marrow Transplant. 2004 Dec;34(11):963-8.

PMID:
15489869
20.

Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.

Chawla SP, Grunberg SM, Gralla RJ, Hesketh PJ, Rittenberg C, Elmer ME, Schmidt C, Taylor A, Carides AD, Evans JK, Horgan KJ.

Cancer. 2003 May 1;97(9):2290-300.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk